HAWKINS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HAWKINS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	484	504	556	540	597	775	935	919	974	1,084
Cost of revenue	386	417	460	439	473	628	770	726	749	839
Gross profit	98.1	86.8	95.9	101	124	147	165	194	226	245
Selling, general and administrative	59.4	59.4	59.1	59.2	67.9	75.3	77	89.6	106	124
Operating income	38.7	-11.8	36.8	41.7	55.9	71.2	88.2	104	119	121
Other non-operating income	0	0.09	0.07	-0.2	1.44	0.19	-0.33	1.39	0.64	1.55
Pre-tax income	36	-15.1	33.5	39	55.9	70	82.6	101	114	109
Income tax	13.5	-5.9	9.1	10.6	14.9	18.4	22.5	25.8	30	27.8
Net income	22.6	-9.18	24.4	28.4	41	51.5	60	75.4	84.3	81.5
EBITDA	59.6	10.6	58.6	63.3	78.5	95.3	116	136	159	174
EPS, basic	1.07	-0.44	1.15	1.34	1.95	2.46	2.88	3.61	4.05	3.93
EPS, diluted	1.07	-0.43	1.14	1.33	1.93	2.44	2.86	3.59	4.03	3.91
Shares, basic (weighted)	21.1	21.2	21.3	21.2	21	20.9	20.8	20.9	20.8	20.7
Shares, diluted (weighted)	21.2	21.3	21.5	21.3	21.3	21.1	21	21	20.9	20.9
Dividend per share	0.42	0.44	0.34	0.46	0.47	0.52	0.57	0.63	0.70	0.75

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	6.86	4.99	9.2	4.28	3	3.5	7.57	7.15	5.1	3.91
Receivables	57.3	63.5	64	67.4	90.6	123	129	114	132	140
Inventory	51.2	59.7	60.5	54.4	63.9	95	88.8	74.6	83.5	78.2
Other current assets	4.24	4.11	5.24	4.93	5.54	6.43	6.45	6.6	7.42	9.56
Total current assets	121	135	139	131	163	228	232	203	231	231
Property, plant and equipment	122	124	119	126	145	162	186	209	225	266
Lease right-of-use assets			0	9.09	11.6	10.6	10.2	11.7	13.4	16.8
Goodwill	97.6	58.4	58.4	58.4	70.7	77.4	77.4	103	135	223
Intangible assets	76.9	71.2	65.7	60.7	76.4	80.2	73.1	117	150	233
Other non-current assets	1.69	2.56	3.4	3.77	0.49	2.76	4.66	4.91	3.91	2.99
Total assets	419	391	386	389	473	567	591	658	770	986
Accounts payable	29.8	33.4	29.3	34.1	37.3	66.7	53.7	56.4	61.2	59.8
Accrued liabilities	9.98	8.4	12.5	13.5	18	19	17.3	19.5	19.7	20.1
Deferred revenue									0	1.58
Short-term debt	7.99	9.86	9.91	9.91	9.91	9.91	9.91	9.91	9.91
Total current liabilities	55.7	60.6	55.4	62.2	70.5	101	90.9	103	97.2	105
Long-term debt	94.6	90.8	74.7	49.8	88.8	116	102	88.8	149	244
Lease liabilities			0	7.65	10.2	9.14	8.69	9.53	10.9	14.5
Other non-current liabilities	2.45	4.39	5.7	1.11	1.37	2.37	2.18	1.31	1.37	1.36
Total liabilities	201	189	168	156	207	265	241	252	310	452
Total debt	103	101	85	60	99	126	112	99	149	244
Paid-in capital	51.1	53.9	52.6	50.4	51.1	46.7	44.4	38.2	24.1	32.7
Retained earnings	166	147	164	183	214	254	302	365	434	500
Other comprehensive income	0.3	0.6	0.32	-0.08	0	1.29	2.94	3.12	1.73	0.98
Shareholders' equity	218	202	218	233	265	303	350	406	460	534
Total equity	218	202	218	233	265	303	350	406	460	534
Total liabilities and equity	419	391	386	389	473	567	591	658	770	986
Shares outstanding	21.2	21.3	10.6	21	21	20.9	20.9	20.8	20.7	20.8

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	22.6	-9.18	24.4	28.4	41	51.5	60	75.4	84.3	81.5
Depreciation and amortization	20.9	22.4	21.8	21.6	22.7	24.1	27.4	31.8	39.9	52.5
Stock-based compensation	2.13	1.37	2.01	2.27	3.34	3.82	3.83	4.88	6.5	8.57
Deferred income tax	-0.53	-14.8	-0.61	-1.42	-0.69	-1.5	-0.23	-1.46	0.46	3.05
Change in receivables	2.26	-6.16	-0.49	-3.39	-21.3	-30.5	-6.39	21.4	-11.2	-2.47
Change in inventory	-3.53	-8.49	-0.75	6.05	-7.96	-30	4.72	19.9	-6.57	10.1
Change in payables	0.56	4.16	-4.14	4.23	2.55	25.1	-11.6	-0.83	2.45	-5.84
Cash from operations	44.9	27.3	48	58.9	43.8	42.8	77.4	159	111	144
Capital expenditures	-21.6	-19.7	-12.6	-24.5	-20.8	-28.5	-48.3	-40.2	-41.1	-58.2
Acquisitions	-2.2	0	0	0	-51	-21.5	0	-83.5	-87.4	-167
Purchases of investments	0	0
Sales and maturities of investments	0	0
Cash from investing	-23.5	-19.3	-12.3	-24.2	-71.4	-49.8	-41.2	-123	-128	-224
Debt repaid	-5.63	-8.13	-85	0	0
Stock issued	1.29	1.41	1.34	1.4	1.58	1.77	2.01	2.24	2.66	3.04
Share buybacks	0	0	-4.35	-5.85	-4.14	-8.55	-6.56	-11.3	-20.7	0
Dividends paid	-8.68	-9.16	-12	-9.83	-10	-11.1	-12	-13.2	-14.6	-15.7
Cash from financing	-34.5	-9.88	-31.4	-39.6	26.4	7.42	-32.1	-37.4	14.8	78.6
Net change in cash	-13.2	-1.87	4.21	-4.92	-1.28	0.5	4.07	-0.41	-2.05	-1.19
Free cash flow	23.2	7.65	35.4	34.4	23	14.3	29.1	119	70	86.1
Interest paid	2.34	3.03	3.16	2.41	1.29	1.2	4.76	4.65	5.79	13.7
Income taxes paid	13.4	10.2	7.59	11.4	15.8	19.7	19.5	28.6	34.4	22.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $129.03 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	22.3%	Gross profit / revenue.
Operating margin	10.7%	Operating income / revenue.
EBITDA margin	15.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Net margin	7.3%	Net income / revenue.
FCF margin	8.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	13.4%	Cash from operations / revenue.
Return on equity (ROE)	14.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	8.0%	Net income / average total assets.
Return on invested capital (ROIC)	12.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	11.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	5.1%	Capital expenditures / revenue.
D&A / revenue	4.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	11.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	12.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	8.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	14.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	14.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	1.8%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	11.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	16.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	9.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	14.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	17.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-3.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	10.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	14.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-3.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	11.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	15.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	29.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	23.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	26.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	23.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	43.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	30.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	7.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	9.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	9.7%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	16.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	15.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	15.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	28.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	18.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	15.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.27x	Current assets / current liabilities.
Quick ratio	1.46x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.07x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.45x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	24.2%	Total debt / total assets.
Liabilities / assets	45.5%	Total liabilities / total assets.
Net debt	$236.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.37x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$139.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	45.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$95.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.10x	Revenue / average total assets.
Fixed asset turnover	4.09x	Revenue / average property, plant and equipment.
Inventory turnover	10.8x	Cost of revenue / average inventory.
Days inventory	34 days	365 x average inventory / cost of revenue.
Receivables turnover	7.29x	Revenue / average receivables.
Days sales outstanding	50 days	365 x average receivables / revenue.
Days payables	27 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	57 days	Days inventory + days sales outstanding - days payables.
FCF conversion	113.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	38.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.87	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$53.04	Revenue / diluted weighted shares.
FCF per share	$4.40	Free cash flow / diluted weighted shares.
Operating cash flow per share	$7.10	Cash from operations / diluted weighted shares.
Book value per share	$26.43	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$4.60	Tangible book value / shares outstanding.
Cash per share	$0.38	(Cash + short-term investments) / shares outstanding.
Payout ratio	19.7%	Dividends paid / net income, when net income is positive.
Dividends / FCF	17.3%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	7.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.69B	Share price x shares outstanding.
Enterprise value	$2.93B	Market cap + total debt - cash - short-term investments.
P/E	33.4x	Market cap / net income. Only when net income is positive.
P/S	2.44x	Market cap / revenue.
P/B	4.91x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	28.2x	Market cap / tangible book value, when positive.
P/FCF	29.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	18.2x	Market cap / cash from operations, when positive.
EV/Sales	2.65x	Enterprise value / revenue.
EV/EBIT	24.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	17.0x	Enterprise value / EBITDA, when both are positive.
EV/FCF	32.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.4%	Free cash flow / market cap.
Earnings yield	3.0%	Net income / market cap (the inverse of P/E).
Dividend yield	0.6%	Dividends paid over the period / market cap.
Shareholder yield	0.9%	(Dividends paid + share buybacks) / market cap.
PEG	3.04x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was HAWKINS INC's revenue in fiscal 2026?

HAWKINS INC reported revenue of $1.08B for fiscal 2026, 11.2% higher than the year before.

Was HAWKINS INC profitable in fiscal 2026?

Yes. Net income was $81.5M, a net margin of 7.5%.

How much free cash flow did HAWKINS INC generate in fiscal 2026?

Cash from operations of $144.3M minus capital expenditures of $58.2M left free cash flow of $86.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HAWKINS INC